Ipamorelin
A selective peptide discussed in relation to growth-hormone-pulse signaling.
A selective peptide discussed in relation to growth-hormone-pulse signaling.
Ipamorelin is a selective peptide studied for how it may prompt a growth-hormone pulse through the ghrelin-receptor pathway — a different route than GHRH analogs.
It is often discussed as comparatively selective, with less reported effect on other hormones. “Selective” is a useful description, not a promise of safety or benefit.
It is a selective GH secretagogue.
Acts through a different receptor than GHRH analogs.
“Selective” describes behavior, not guaranteed outcomes.
It is described as mimicking ghrelin at its receptor and dampening somatostatin (a signal that slows GH release), which is why it is frequently paired with GHRH analogs in discussion.
It appears in GH-axis conversations, usually as a complement to CJC-1295 or Sermorelin.
Discussed as an injectable in research settings. Context and oversight determine appropriateness.
This content is for informational and educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before making decisions related to your health.
